Edgestream Partners L.P. Boosts Stake in Bruker Co. (NASDAQ:BRKR)

Edgestream Partners L.P. grew its holdings in shares of Bruker Co. (NASDAQ:BRKR) by 602.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 111,805 shares of the medical research company’s stock after purchasing an additional 95,897 shares during the period. Edgestream Partners L.P. owned approximately 0.07% of Bruker worth $6,554,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in BRKR. True Wealth Design LLC grew its position in Bruker by 4,636.4% during the 3rd quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock worth $36,000 after purchasing an additional 510 shares during the period. Eagle Bay Advisors LLC increased its holdings in shares of Bruker by 2,324.1% during the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock worth $41,000 after buying an additional 674 shares during the last quarter. UMB Bank n.a. increased its holdings in shares of Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock worth $53,000 after buying an additional 248 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Bruker by 47.5% during the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock worth $75,000 after buying an additional 412 shares during the last quarter. Finally, Capital Performance Advisors LLP acquired a new stake in Bruker in the 3rd quarter valued at approximately $77,000. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Analyst Upgrades and Downgrades

BRKR has been the subject of several research reports. Bank of America boosted their price target on shares of Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Barclays reduced their price target on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. UBS Group started coverage on shares of Bruker in a report on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 target price for the company. Stifel Nicolaus dropped their price target on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research note on Friday, February 14th. Finally, The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price on the stock in a research report on Thursday, December 5th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $70.50.

Bruker Stock Up 2.8 %

NASDAQ BRKR opened at $48.20 on Friday. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. The company’s 50 day simple moving average is $55.37 and its 200 day simple moving average is $59.28. Bruker Co. has a 12 month low of $45.29 and a 12 month high of $94.86. The company has a market capitalization of $7.31 billion, a P/E ratio of 63.42, a PEG ratio of 2.16 and a beta of 1.16.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Equities research analysts expect that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Monday, March 17th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend is Monday, March 17th. Bruker’s payout ratio is currently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.